- • Up to 20% off your first purchase
- • Bulk quantities available
- • Citation Reward application
Sample Application
- Animal health test
- In-vitro diagnostics
- Food & Feed Safety
- Environmental Safety
- New drug discovery
Supports
- Talk to our Expert:
[email protected] -
Talk to our sales:
[email protected]
Protocol Library Download
 |
 |
Fibrinogen (FIB) antibody and antigen (Recombinant protein)
Diagnostic Fibrinogen (FIB) antibodies (anti-Fibrinogen, anti-FIB) and antigens (recombinant Fibrinogen (FIB) protein) for Fibrinogen disorders FIB detection in ELISA, colloidal gold-based Lateral flow immunoassay (LFIA), CLIA, TINIA and POCT.
Go to Fibrinogen disorders diagnostics products collection
>>
Product information
| Catalog No. | Description | US $ Price (per mg) |
|---|---|---|
| GMP-h-FIB-Ag01 | Recombinant human FIB Protein | $3090.00 |
| GMP-h-FIB-Ab01 | Anti-human FIB mouse monoclonal antibody (mAb) | $1953.00 |
| GMP-h-FIB-Ab02 | Anti-human FIB mouse monoclonal antibody (mAb) | $1953.00 |
| GMP-h-FIB-Ab03 | Anti-human FIB human monoclonal antibody (mAb) | $1953.00 |
| GMP-h-FIB-Ab04 | Anti-human FIB human monoclonal antibody (mAb) | $1953.00 |
Size： 1mg | 10mg | 100mg
Product Description
| Cat No. of Pruducts | GMP-h-FIB-Ag01 |
| Product Name | Recombinant human FIB Protein |
| Target/Biomarker | Fibrinogen (FIB) |
| Alias of Target/Biomarker | FIB, FLRN, Nop1, RNU3IP1 |
| Expression platform | mammalian |
| Isotypes | Recombinant Antigen |
| Bioactivity validation | Fibrinogen (FIB) antibodies binding, Immunogen in Sandwich Elisa, lateral-flow tests, and other immunoassays as control material in FIB level test of Fibrinogen disorders (congenital afibrinogenemia, congenital hypofibrinogenemia, fibrinogen storage disease, congenital dysfibrinogenemia, hereditary fibrinogen Aα-Chain amyloidosis, acquired dysfibrinogenemia, congenital hypodysfibrinogenemia, and cryofibrinogenemia) and related syndrome evaluation |
| Products description | Recombinant Human protein was expressed in mammalian cell expression system and is expressed with 6 HIS tag at the C-terminus. |
| Purity | Purity: ≥95% (SDS-PAGE) |
| Application | positive control, ELISA test,Lateral flow immunoassay (LFIA),colloidal gold immunochromatographic assay, Chemiluminescent immunoassay (CLIA),turbidimetric inhibition immuno assay (TINIA) and Immunonephelometry. |
| Formulation | Supplied as a 0.2 μM filtered solution of PBS,PH7.4. |
| Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
| Cat No. of Pruducts | GMP-h-FIB-Ab01,GMP-h-FIB-Ab02 |
| Product Name | Anti-human FIB mouse monoclonal antibody (mAb) |
| Target/Biomarker | Fibrinogen (FIB) |
| Alias of Target/Biomarker | FIB, FLRN, Nop1, RNU3IP1 |
| Expression platform | CHO |
| Isotypes | Mouse IgG |
| Bioactivity validation | Human Fibrinogen (FIB) antigen binding, ELISA validated as capture antibody and detection antibody. Pair recommendation with other Fibrinogen (FIB) antibodies in FIB level test of Fibrinogen disorders (congenital afibrinogenemia, congenital hypofibrinogenemia, fibrinogen storage disease, congenital dysfibrinogenemia, hereditary fibrinogen Aα-Chain amyloidosis, acquired dysfibrinogenemia, congenital hypodysfibrinogenemia, and cryofibrinogenemia) and related syndrome evaluation. |
| Tag | mFc |
| Products description | Anti-human FIB mouse monoclonal antibody (mAb) is a mouse monoclonal antibody produced by CHO technology. The antibody is ELISA validated as capture antibody and detection antibody. Pair recommendation with other Fibrinogen (FIB) antibodies. |
| Reconized/Reactive Species | Human |
| Purity | Purity: ≥95% (SDS-PAGE) |
| Application | ELISA test,Lateral flow immunoassay (LFIA),colloidal gold immunochromatographic assay, Chemiluminescent immunoassay (CLIA),turbidimetric inhibition immuno assay (TINIA),immunonephelometry and POCT. |
| Formulation | Supplied as a 0.2 μM filtered solution of PBS,PH7.4. |
| Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
| Cat No. of Pruducts | GMP-h-FIB-Ab03,GMP-h-FIB-Ab04 |
| Product Name | Anti-human FIB human monoclonal antibody (mAb) |
| Target/Biomarker | Fibrinogen (FIB) |
| Alias of Target/Biomarker | FIB, FLRN, Nop1, RNU3IP1 |
| Expression platform | CHO |
| Isotypes | Human lgG1 |
| Bioactivity validation | Human Fibrinogen (FIB) antigen binding, ELISA validated as capture antibody and detection antibody. Pair recommendation with other Fibrinogen (FIB) antibodies in FIB level test of Fibrinogen disorders (congenital afibrinogenemia, congenital hypofibrinogenemia, fibrinogen storage disease, congenital dysfibrinogenemia, hereditary fibrinogen Aα-Chain amyloidosis, acquired dysfibrinogenemia, congenital hypodysfibrinogenemia, and cryofibrinogenemia) and related syndrome evaluation. |
| Tag | hFc |
| Products description | Anti-human FIB mouse monoclonal antibody (mAb) is a human monoclonal antibody produced by CHO. The antibody is ELISA validated as capture antibody and detection antibody pair. |
| Reconized/Reactive Species | Human |
| Purity | Purity: ≥95% (SDS-PAGE) |
| Application | ELISA test,Lateral flow immunoassay (LFIA),colloidal gold immunochromatographic assay, Chemiluminescent immunoassay (CLIA),turbidimetric inhibition immuno assay (TINIA),immunonephelometry and POCT. |
| Formulation | Supplied as a 0.2 μM filtered solution of PBS,PH7.4. |
| Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
Reference
Validation Data
Click to get more Data / Case study about the product.
Target/Biomarker information
Fibrinogen (factor I) is a glycoprotein complex, produced in the liver, that circulates in the blood of all vertebrates. During tissue and vascular injury, it is converted enzymatically by thrombin to fibrin and then to a fibrin-based blood clot. It helps create blood clots, heal wounds, and grow new blood vessels in response to injury, infection, or inflammation. Fibrinogen disorders are a set of hereditary or acquired abnormalities in the quantity and/or quality of circulating fibrinogens. These disorders include, congenital afibrinogenemia, congenital hypofibrinogenemia, fibrinogen storage disease, congenital dysfibrinogenemia, hereditary fibrinogen Aα-Chain amyloidosis, acquired dysfibrinogenemia, congenital hypodysfibrinogenemia, and cryofibrinogenemia.
About GDU
GDU helps global diagnostic partners in high quality of raw material discovery, development, and application. GDU believes in Protein&antibody Innovation for more reliable diagnostic solutions.
Facebook
LinkedIn
Twitter
Comments